Related Experiment Video

Updated: May 13, 2026

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Authors reply: influenza vaccine effectiveness: heterogeneity in estimates for the 2012/13 season

K Molbak, H D Emborg, S Gubbels

    Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
    |March 2, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
    05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    Related Experiment Videos

    Last Updated: May 13, 2026

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
    08:52

    Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

    Published on: July 26, 2019

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
    05:21

    A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

    Published on: August 14, 2019

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

    Articles linked to this work by shared authors, journal, and citation graph.

    Feasibility and Effects of Exercise During Working Hours in Acute Hospital Staff - A Non-Randomized Controlled Trial.

    Journal of occupational rehabilitation·2025

    Automated surveillance systems for healthcare-associated infections: results from a European survey and experiences from real-life utilization.

    The Journal of hospital infection·2022

    Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.

    Vaccine·2021

    Severity of COVID-19 at elevated exposure to perfluorinated alkylates.

    medRxiv : the preprint server for health sciences·2020

    Risk factors for surgical site infections in abdominal surgeries in Ghana: emphasis on the impact of operating rooms door openings.

    Epidemiology and infection·2020

    Detection of norovirus infections in Denmark, 2011-2018.

    Epidemiology and infection·2020

    Patterns in the dynamics of respiratory viruses after the COVID-19 pandemic: an observational, retrospective study using sentinel surveillance network data, Catalonia, 2022 to 2025.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

    Nationwide outbreak of Salmonella Enteritidis linked to consumption of pumpkin seeds, France, 2026.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

    Increase in congenital syphilis in the European Union and European Economic Area, 2015 to 2024 - time to scale-up public health responses.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

    Factors driving increases in Clostridioides difficile infection rates in England: a national case-control study, 2019 to 2024.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

    Identifying socioeconomic characteristics of pregnant women aged 15-50 years diagnosed with HIV during pregnancy, the Netherlands, 2016 to 2023.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

    Characteristics and outcomes of adult patients hospitalised with RSV infection, influenza or COVID-19 in Belgium, winter seasons 2023/24 and 2024/25.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us